Histidine ammonia lyase (HAL) isolated from Corynebacteriaceae can decrease serum histidine levels, induce accumulation of urocanic acid, and is not inhibited by L-histidinol. As a result, histidine ammonia lyases similar to the one isolated from Corynebacteriaceae are uniquely suitable for combination therapy with L-histidinol to treat histidine- and/or histamine-dependent pathologies, for example, infectious viruses, such as human Respiratory Syncytial Virus (RSV), Herpes Simplex Virus (HSV), and Human Immunodeficiency Virus (HIV), as well as cancers.

 
Web www.patentalert.com

< Directionally cloned random cDNA expression vector libraries, compositions and methods of use

< Polynucleotide encoding a novel metalloprotease highly expressed in the testis, MMP-29

> Specific binding agents for KSHV vIL-6 that neutralize a biological activity

> Antibodies against mouse pituitary tumor transforming gene carboxy-terminal (PTTG-C) peptides

~ 00206